Part:BBa_K2404018:Design
TSH antagonist under control of the PDF1.2 promoter
- 10INCOMPATIBLE WITH RFC[10]Illegal PstI site found at 1048
Illegal PstI site found at 1090 - 12INCOMPATIBLE WITH RFC[12]Illegal PstI site found at 1048
Illegal PstI site found at 1090 - 21INCOMPATIBLE WITH RFC[21]Illegal BglII site found at 412
Illegal BamHI site found at 1303
Illegal XhoI site found at 1115 - 23INCOMPATIBLE WITH RFC[23]Illegal PstI site found at 1048
Illegal PstI site found at 1090 - 25INCOMPATIBLE WITH RFC[25]Illegal PstI site found at 1048
Illegal PstI site found at 1090 - 1000COMPATIBLE WITH RFC[1000]
Design Notes
Experimental design for composite part construction:
We conducted a Type IIS restriction enzyme digest using the BsaI enzyme. The reaction mix includes three level 0 plasmid
> Restriction digest at 37C
- BsaI
- Enzyme buffer
- Level 0 plasmid containing PDF1.2
- Level 0 plasmid containing TSHH
- Level 1 plasmid pGB-A2
> Inactivate enzyme at 80C
> Add T4 ligase
> Transform E.coli and plate onto kanamycin (50ug/ul) plates
This part was created using golden gate assembly, and thus has typeIIS restriction enzyme recognition sites flanking it.
Source
The CDS was synthesised, the promoter isolated from Arabidopsis thaliana , and the terminator isolated from Agrobacterium tumefaciens